[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367375-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367375-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","slc25a42-promotes-gastric-cancer-growth-by-conferring-ferroptosis-resistance-through-enhancing-cpt2-mediated-fatty-acid-oxidation","SLC25A42 promotes gastric cancer growth by conferring ferroptosis resistance through enhancing CPT2-mediated fatty acid oxidation","","SLC25A42, a mitochondrial coenzyme A (CoA) transporter, is investigated for its roles in gastric cancer. The study finds SLC25A42 upregulated in gastric cancer patients and associated with worse prognosis. In vitro and in vivo experiments show SLC25A42 promotes proliferation and suppresses apoptosis while inhibiting ferroptosis. Mechanistically, SLC25A42 reprograms lipid metabolism by enhancing fatty-acid-oxidation–driven mitochondrial respiration and decreasing free fatty acids and ROS, alongside CPT2 upregulation via increased acetylation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/slc25a42-promotes-gastric-cancer-growth-by-conferring-ferroptosis-resistance-through-enhancing-cpt2-mediated-fatty-acid-oxidation/367375/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/slc25a42-promotes-gastric-cancer-growth-by-conferring-ferroptosis-resistance-through-enhancing-cpt2-mediated-fatty-acid-oxidation/367375.png","ImageObject",300,407,{"name":42,"@type":43},"Jacob","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is SLC25A42 and what role does it play in the study?","Question",{"text":63,"@type":64},"SLC25A42 is a mitochondrial protein that governs CoA transport. The study evaluates how its expression influences gastric cancer growth, apoptosis, and ferroptosis through lipid metabolism reprogramming.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does SLC25A42 affect gastric cancer cell behavior?",{"text":68,"@type":64},"SLC25A42 promotes proliferation of gastric cancer cells and suppresses apoptosis in vitro and in vivo. It also inhibits ferroptosis, supporting tumor cell survival.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism links SLC25A42 to ferroptosis resistance and CPT2?",{"text":72,"@type":64},"SLC25A42 enhances fatty acid oxidation-mediated mitochondrial respiration while reducing free fatty acids and ROS to suppress ferroptosis. It further increases acetylation that upregulates CPT2 expression, reprogramming lipid metabolism in gastric cancer cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367375,1790204084,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},962084931830,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nSLC25A42 promotes gastric cancer growth by conferring ferroptosis resistance through enhancing CPT2-mediated fatty acid oxidation  \nHaoying Wang1,5, Weijia Dou 1,5, Mengxiao Liu2,5, Weifang Wang3, Ying Yang4, Jibin Li3 ✉, Zhenxiong Liu1 ✉ and Nan Wang 4 ✉  \n© The Author(s) 2025  \n|  |  |  |\n| --- | --- | --- |\n|  | Accumulating evidence has shown that the dysfunction of mitochondria, the multifunctional organelles in various cellular processes, is a pivotal event in the development of various diseases, including human cancers. Solute Carrier Family 25 Member 42 (SLC25A42) is a mitochondrial protein governing the transport of coenzyme A (CoA) . However, the biological roles of SLC25A42 inhuman cancers are still unexplored. Here we uncovered that SLC25A42 is upregulated and correlated with a worse prognosis in GC patients. SLC25A42 promotes the proliferation of gastric cancer (GC) cells while suppresses apoptosis in vitro and in vivo. Mechanistically, SLC25A42 promotes the growth and inhibits apoptosis of GC cells by reprograming lipid metabolism. On the one hand, SLC25A42 enhances fatty acid oxidation-mediated mitochondrial respiration to provide energy for cell survival. On the other hand, SLC25A42 decreases the levels of free fatty acids and ROS to inhibit ferroptosis. Moreover, we found that SLC25A42 reprograms lipid metabolism in GC cells by upregulating the acetylation and thus the expression of CPT2 . Collectively, our data |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| reveal a critical oncogenic role of SLC25A42 in GCs and suggest that SLC25A42 represent a promising therapeutic target for GC. |  |  |\n|  | Cell Death and Disease (2025)16:309; [https://doi.org/10.1038/s41419-025-07644-7](https://doi.org/10.1038/s41419-025-07644-7) |  |\n|  |  |  |\n\nINTRODUCTION  \nGastric cancer (GC) is one of the deadly malignancies worldwide [1] . Despite advancements in surgical techniques, chemotherapy and radiotherapy, the prognosis of GC patients remains poor due to the absence of effective targeted therapies [2], highlighting the urgent need for further explorations of the key molecular factors driving the initiation and progression gastric cancer to unlock speciﬁc therapeutic strategy and target to improve the patient outcomes.  \nMitochondria not only serve as the “powerhouse” of cells for energy production, but also act as multifunctional organelles in various critical cellular processes, including cell survival and cell death, production of reactive oxygen species (ROS), and maintenance of calcium equilibrium [3] . These essential functions of mitochondria support a wide array of cellular processes, including bioenergetics, biosynthetic, and oncogenic signaling pathways throughout the process of tumorigenesis [4] . Perturbations of mitochondrial have been frequently observed in various physiological disorders, including cancer [5, 6] . However, the factors leading to the abnormal mitochondrial function in cancer cells remain not fully elucidated.  \nSolute carrier family 25 (SLC25) is the largest mitochondrial carrier family (consist 53 members), which transport solutes across the inner membrane of mitochondria [7] . Among these carriers, SLC25A42 plays a crucial role in the transport of mitochondrial coenzyme A (CoA) [8, 9], which is an essential cofactor in  \nnumerous biochemical reactions, including the tricarboxylic acid cycle, nutrient oxidation, histone acetylation, and synthesis of lipids [10] . Mutations in SLC25A42 have been associated with mitochondrial myopathy [11] and encephalomyopathy [12] in humans, highlighting the importance of SLC25A42 in normal physiological functions. However, the biological roles of SLC25A42 in human cancer progression are still unexplored.  \nThis study focused on the roles and mechanisms of SLC25A42 in the metabolism and malignant properties in gastric cancer cells. We found that SLC2","cbCaihNqN6Oquy5p","https://ap.wps.com/l/cbCaihNqN6Oquy5p","pdf",4504451,12,"English","# Introduction\n# Materials and Methods\n## Clinical samples\n## Cell lines\n## Quantitative PCR (qPCR)","[{\"question\":\"What is SLC25A42 and what role does it play in the study?\",\"answer\":\"SLC25A42 is a mitochondrial protein that governs CoA transport. The study evaluates how its expression influences gastric cancer growth, apoptosis, and ferroptosis through lipid metabolism reprogramming.\"},{\"question\":\"How does SLC25A42 affect gastric cancer cell behavior?\",\"answer\":\"SLC25A42 promotes proliferation of gastric cancer cells and suppresses apoptosis in vitro and in vivo. It also inhibits ferroptosis, supporting tumor cell survival.\"},{\"question\":\"What mechanism links SLC25A42 to ferroptosis resistance and CPT2?\",\"answer\":\"SLC25A42 enhances fatty acid oxidation-mediated mitochondrial respiration while reducing free fatty acids and ROS to suppress ferroptosis. It further increases acetylation that upregulates CPT2 expression, reprogramming lipid metabolism in gastric cancer cells.\"}]","SLC25A42 promotes gastric cancer growth by conferring ferroptosis resistance through enhancing CPT2-mediated fatty acid oxidation | PDF",1790170516,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/114c309d00b7aec233d968690fdaf5dc.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c8cbfc6fea64b09258fd0079d377220.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9970909147c45527189dfa7490f0b25.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e762af2c8d1fa99ee958d6ae5665133.webp",980,1301]